The biological mechanisms underlying MASLD leading to HCC involve the release of inflammatory cytokines (such as TNF-α, IL6) and reduced adiponectin levels that promote insulin resistance, which in turn inhibits fatty acid oxidation, leading to DNA damage and mutations. Here, IL6 is linked to hepatocellular carcinoma.